How can India address the challenge of HIV strains developing resistance to broadly neutralising antibodies?
The news mentions that HIV strains in India are showing resistance to some of the top broadly neutralising antibodies. I want to understand what strategies or policies can be used to tackle this issue and what challenges might arise in implementing them.